Advertisement
U.S. markets close in 5 hours 28 minutes
  • S&P 500

    5,250.28
    +1.79 (+0.03%)
     
  • Dow 30

    39,729.09
    -30.99 (-0.08%)
     
  • Nasdaq

    16,386.93
    -12.59 (-0.08%)
     
  • Russell 2000

    2,121.16
    +6.81 (+0.32%)
     
  • Crude Oil

    82.37
    +1.02 (+1.25%)
     
  • Gold

    2,227.70
    +15.00 (+0.68%)
     
  • Silver

    24.79
    +0.04 (+0.15%)
     
  • EUR/USD

    1.0811
    -0.0019 (-0.17%)
     
  • 10-Yr Bond

    4.1980
    +0.0020 (+0.05%)
     
  • GBP/USD

    1.2642
    +0.0004 (+0.03%)
     
  • USD/JPY

    151.2870
    +0.0410 (+0.03%)
     
  • Bitcoin USD

    71,069.66
    +1,256.31 (+1.80%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,962.95
    +30.97 (+0.39%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Hemispherx, Bioclones to collaborate on HIV/AIDS eradication

Hemispherx Biopharma announced execution of an agreement to seek South African government approval to initiate a study of Alferon N, the only FDA approved natural interferon, in the suppression of HIV Type 1 replication and the reduction/elimination of functional cell-associated HIV DNA integration. The study is contemplated as part of a broad strategic alliance with Bioclones, a South African biotechnology company. At the Wistar Institute, University of Pennsylvania, a recent clinical study was conducted to test the effect of Interferon Alfa-2a in the suppression and/or eradication of HIV. This pilot study yielded an exciting conclusion: alpha interferon resulted in control of HIV replication in 45% of patients following cessation of anti-retroviral therapy. Decreased levels of latent HIV occurred in patients in which HIV replication was suppressed by anti-retroviral drugs, supporting a role for immune-mediated approaches in HIV suppression and potential eradication of latent virus required for cure. Hemispherx' flagship products, Alferon N and Ampligen are both potentially key players in successful long-term immune-mediated therapy.

Advertisement